Recently, some netizens said that there is a popular way of losing weight by injections on friends groups and social platforms. Some people said that they lost 20 pounds after 6 injections, and some said they lost 10 pounds in 7 days.

The Beijing Youth Daily reporter learned that this injection is actually a prescription drug for the treatment of diabetes.

　　Phenomenon

　　It is said that weight loss has "miraculous effects"

　　Medication for low blood sugar

　　"Three months, I lost almost 10 pounds." Xiaoying (pseudonym) is a diabetic patient. She is not announcing the weight loss effect, but is introducing to the reporter of Beijing Youth Daily that she was injected with GLP-1 receptor stimulation for treatment. Changes in body weight after dosing.

　　"The first injection was very severe. Sometimes I couldn't eat, and I didn't want to eat. Once I took it hard, I would vomit, and my appetite gradually became smaller. Because this drug is a prescription drug, it must be prescribed by a doctor after diagnosis. And it can be purchased and used under the guidance of a doctor. The hospital I went to said that this medicine is out of stock, because it is used once a week, and now I can only temporarily stop the medicine and buy it after the goods arrive.” Xiaoying said.

　　Yuanyuan (pseudonym), who is also using similar drugs, is for another purpose - losing weight.

With a height of 168 centimeters and a weight of 130 pounds, she is not perfect.

Yuanyuan's weight goal is to reach the previous 108 pounds.

"I heard that a lot of people have been given this injection recently. It directly suppresses their appetite. They are not hungry every day, and the side effects are small. Although it is a prescription drug, it can also be bought online at any time, and the requirements are not so strict."

　　investigation

　　Online shopping without a prescription

　　The price ranges from 300 to 3000 yuan

　　Can prescription pills be bought online?

The Beiqing Daily reporter dubiously searched the online shopping platform and found that there were more than 4,000 results for GLP-1 receptor agonist products.

　　From the perspective of categories, there are two doses of 1.5 mg and 3 mg per injection, and the price ranges from 300-3000 yuan according to different packaging such as standard, 3 boxes, and 5 boxes.

Some stores have a monthly sales volume of up to more than 200 orders, but because of the need for cold chain transportation, some merchants set the shipping fee as high as 180 yuan.

　　When a reporter from Beiqing Daily asked customer service whether such drugs could be used for weight loss, many merchants directly replied "yes", and some said "not recommended".

The Beiqing Daily reporter noticed that the purchase page cannot directly place an order for purchase. The first step must be to fill in the consultation information including name, ID card, mobile phone number, diagnosed disease, prescription, etc.

In this regard, the customer service explained that because it is a prescription drug, the system requires the submission of any one of the prescription list, case, and inspection report before placing an order for purchase.

　　However, for buyers who want to buy medicine without a prescription, a customer service revealed: "You can leave your contact information to communicate by phone. After private transfer, the merchant will ship the goods directly, which can avoid the review of the online shopping platform system."

　　expert

　　Not State Approved for Weight Loss

　　Doctors do not recommend these drugs for weight loss

　　On social platforms, some people calculated that they lost about 4 pounds in 12 days and 10 pounds in 27 days, but the side effects such as vomiting, nausea and constipation came with the weight loss.

　　It is understood that these injections, as prescription drugs, must be prescribed by a physician who has the right to prescribe in a medical institution before they can be used.

In this regard, a chief physician of the endocrinology department introduced to a reporter from Beiqing Daily that the GLP-1 receptor agonists currently on the market are used to treat diabetes, and they are used under the guidance of doctors. Some are injected once a week, and some are injected every day. of.

It is indeed possible to lose weight on the basis of lowering blood sugar and blood lipids.

The principle is that by inhibiting the feeding center, the patient's appetite is reduced, and gastric emptying is inhibited.

However, in my country, these drugs are not approved for weight loss, so from the doctor's point of view, it is definitely not recommended for everyone to use it for weight loss.

　　The chief physician explained that the main reason why some people feel that there is a little weight loss after using this drug is that they do not want to eat and reduce their eating.

She reminded that even patients with diabetes should start with small doses, otherwise there will be certain side effects, such as not wanting to eat, loss of appetite, nausea, constipation, and affecting bowel movements.

　　Professor Sun Yanqing, one of the first national health science experts, introduced in an interview with the media that normal people using hypoglycemic drugs may suffer from hypoglycemia, kidney function damage, liver function damage and other damage to other body functions.

The main reasons for obesity are genetics, dietary habits and lack of physical activity.

"It is not advisable to rely on drugs to lose weight. Although it can have a slight effect, it is not symptomatic, and the side effects will outweigh the benefits." Peng Yongde, deputy director of the Endocrinology Branch of the Chinese Medical Association, also said in an interview with the media that my country has not approved these drugs in the For the indications of obesity, all current uses belong to off-label or irregular medication.

　　Memory

　　What are GLP-1 receptor agonists

　　The GLP-1 receptor agonists approved for marketing in my country include polyethylene glycol loxenatide, semaglutide, liraglutide, dulaglutide, etc., which are suitable for the control of blood sugar in adult patients with type 2 diabetes.

According to the duration of action, it can be divided into short-acting and long-acting GLP-1 receptor agonists.

Short-acting GLP-1 receptor agonists require subcutaneous injections multiple times a day, and long-acting GLP-1 receptor agonists can be subcutaneously injected once a day or once a week.

　　Text / reporter Song Xia

　　Coordination / Yu Meiying